Monthly Archives: March 2019

28 March 2019

GeoSpock – Technology Leader Pontus Noren To Join Board

By |March 28th, 2019|

GeoSpock® – the extreme-scale spatial big data integration company that provides analytics, builds insight, and enables predictions across space and time – today announced the appointment of Pontus Noren to a Non-Executive role on its Board of Directors, as well as a £2 million investment from Parkwalk Advisors.

Having recently closed a £10 million funding round, […]

Oxford PV – raises £31m funding

By |March 15th, 2019|

Perovskite solar technology leader announces first close of Series D funding round, attracting major new investment and continued support from existing shareholders
Oxford PVTM – The Perovskite CompanyTM, the leader in the field of perovskite solar cells, today announced it has raised £31 Million, the first portion of its Series D funding round.
The round includes a […]

Phasecraft – Parkwalk investment

By |March 13th, 2019|

Parkwalk are delighted to welcome Phasecraft to its portfolio following an investment from the Parkwalk Opportunities EIS Fund.

Phasecraft is a start-up from researchers at University College London and the University of Bristol. The company was established to develop quantum software for quantum information processors, encompassing both near-term intermediate-scale devices and universal fault-tolerant quantum computers.

Small-scale […]

Paragraf – starts producing graphene at commercial scale

By |March 12th, 2019|

The University of Cambridge has reported that Paragraf, one of its spinouts and a Parkwalk portfolio company, has started producing graphene

A sheet of carbon just one atomic layer thick, at up to eight inches (20cm) in diameter, large enough for commercial electronic devices.

Professor Sir Colin Humphreys, the founding professor of the technology, is quoted […]

Animal Dynamics – Successful Exit

By |March 12th, 2019|

Parkwalk, the leading EIS investor in UK University spin-out companies, is pleased to announce the exit of the majority of its holding in Animal Dynamics via a successful secondary sale.

Parkwalk was one of the initial investors in the company when it was formed in 2015 and has invested in subsequent funding rounds. The sale […]

PredictImmune – announce formal entry of PredictSURE IBD™ into the NICE Diagnostic Assessment Programme

By |March 12th, 2019|

PredictImmune, developers of pioneering prognostic tools for guiding treatment options and improving patient outcomes in immune-mediated diseases, today announced the formal entry of its first product, PredictSURE IBD™, into NICE’s Diagnostic Assessment Programme (DAP).

The DAP evaluates new, cutting-edge medical diagnostic technologies, producing guidance to help people working in the NHS make efficient, cost-effective and […]